S
PACB icon

SignatureFD’s Pacific Biosciences PACB Stock Holding History

SignatureFD’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.16K Sell
1,879
-5,078
-73% -$7.38K ﹤0.01% 3012
2026
Q1 		$9.18K Sell
6,957
-510
-7% -$912 ﹤0.01% 2554
2025
Q4 		$14K Buy
7,467
+2,477
+50% +$4.76K ﹤0.01% 2274
2025
Q3 		$6.39K Buy
4,990
+2,270
+83% +$3.07K ﹤0.01% 2571
2025
Q2 		$3.37K Buy
2,720
+427
+19% +$493 ﹤0.01% 2719
2025
Q1 		$2.71K Sell
2,293
-2,161
-49% -$3.31K ﹤0.01% 2799
2024
Q4 		$8.15K Sell
4,454
-173
-4% -$338 ﹤0.01% 2438
2024
Q3 		$7.87K Buy
4,627
+2,870
+163% +$4.71K ﹤0.01% 2433
2024
Q2 		$2.41K Buy
1,757
+1,095
+165% +$2.21K ﹤0.01% 2715
2024
Q1 		$2.48K Buy
662
+189
+40% +$1.11K ﹤0.01% 2744
2023
Q4 		$4.64K Buy
473
+155
+49% +$1.27K ﹤0.01% 2522
2023
Q3 		$2.65K Hold
318
– – ﹤0.01% 2701
2023
Q2 		$4.23K Hold
318
– – ﹤0.01% 2573
2023
Q1 		$3.68K Sell
318
-61
-16% -$606 ﹤0.01% 2622
2022
Q4 		$3.1K Hold
379
– – ﹤0.01% 2654
2022
Q3 		$2K Buy
379
+83
+28% +$476 ﹤0.01% 2824
2022
Q2 		$1K Sell
296
-222
-43% -$1.35K ﹤0.01% 2976
2022
Q1 		$5K Buy
518
+457
+749% +$5.26K ﹤0.01% 2494
2021
Q4 		$1K Sell
61
-108
-64% -$2.61K ﹤0.01% 2967
2021
Q3 		$4K Buy
+169
New +$5.01K ﹤0.01% 2452
2021
Q2 		– Sell
-17
Closed -$1K – 3020
2021
Q1 		$1K Buy
+17
New +$595 ﹤0.01% 2658
2020
Q1 		– Sell
-247
Closed -$1K – 2409
2019
Q4 		$1K Buy
+247
New +$1.25K ﹤0.01% 2074

Other funds holding PACB

MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return
AF
Advisornet Financial Minnetonka, Minnesota $2.19B AUM 21.28% 1-Year Est. Return
KWM
Koa Wealth Management Encinitas, California $147M AUM 18.41% 1-Year Est. Return
BEI
Benjamin Edwards Inc Clayton, Missouri $11B AUM 18.22% 1-Year Est. Return
KCPG
Kavar Capital Partners Group Leawood, Kansas $812M AUM 29.76% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
APG
Abacus Planning Group Columbia, South Carolina $809M AUM 21.71% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
WA
Wealth Architects Mountain View, California $1.27B AUM 36.93% 1-Year Est. Return

SignatureFD's PACB Position: Q2 2026 in Review

SignatureFD reduced its Pacific Biosciences (PACB) stake by 73% in Q2 2026, selling an estimated $7.38K and leaving 1,879 shares worth $3.16K. The position accounts for ﹤0.01% of the portfolio, ranked #3012.

SignatureFD first reported a position in PACB in Q4 2019 and has held it in 22 quarters since. The position peaked at $14K in Q4 2025. 32 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • SignatureFD held 1,879 shares of Pacific Biosciences worth $3.16K as of Q2 2026.
  • SignatureFD sold 5,078 Pacific Biosciences shares in Q2 2026, an estimated $7.38K.
  • Pacific Biosciences made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #3012 holding.
  • SignatureFD first reported a position in Pacific Biosciences in Q4 2019 and has held it in 22 quarters since.
  • SignatureFD's Pacific Biosciences position peaked at $14K in Q4 2025.
  • 32 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.